achondroplasia
Rare disease · 2022–2022
2decisions
1medicine
2carried consumer input
198individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| vosoritide Treatment of patients with achondroplasia whose epiphyses are not closed. | Jul 2022 | Deferred | 99 individuals |
| vosoritide Treatment of patients with achondroplasia whose epiphyses are not closed. | Nov 2022 | Not recommended | 99 individuals |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 2 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.